Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Current Assets (2019 - 2025)

Historic Current Assets for Bioadaptives (BDPT) over the last 7 years, with Q3 2025 value amounting to $108860.0.

  • Bioadaptives' Current Assets rose 13464.75% to $108860.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $108860.0, marking a year-over-year increase of 13464.75%. This contributed to the annual value of $261885.0 for FY2024, which is 19572.48% up from last year.
  • Latest data reveals that Bioadaptives reported Current Assets of $108860.0 as of Q3 2025, which was up 13464.75% from $255515.0 recorded in Q2 2025.
  • Bioadaptives' Current Assets' 5-year high stood at $261885.0 during Q4 2024, with a 5-year trough of $8735.0 in Q2 2024.
  • Its 5-year average for Current Assets is $84817.1, with a median of $61227.0 in 2022.
  • In the last 5 years, Bioadaptives' Current Assets plummeted by 8229.14% in 2023 and then soared by 282518.6% in 2025.
  • Bioadaptives' Current Assets (Quarter) stood at $88876.0 in 2021, then plummeted by 61.38% to $34324.0 in 2022, then surged by 158.0% to $88557.0 in 2023, then skyrocketed by 195.72% to $261885.0 in 2024, then tumbled by 58.43% to $108860.0 in 2025.
  • Its last three reported values are $108860.0 in Q3 2025, $255515.0 for Q2 2025, and $110448.0 during Q1 2025.